Investigators
Global Reach
Contact

ja

English
日本語

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Services
- Service Sub Menu
Therapeutic Expertise
- Expertise Sub Menu
About
Resource Center
Careers
Investors
- Investor Sub Menu

Request a Proposal

EXPLORE ALL

Drug Development Strategy

Protocol Development & Study Design
Regulatory Consulting
Regulatory Affairs
Quality Assurance
Medical Writing

EXPLORE ALL

Clinical Trial Management

Feasibility & Study Start Up
Project Management
Medical Affairs & Pharmacovigilance
Clinical Monitoring
Patient Recruitment
Biometrics
Training Academy

Functional Services Provider

Coming Soon

Request a Proposal
Global Reach
Investigators

Drug Development Strategy

Protocol Development & Study Design
Regulatory Consulting
Regulatory Affairs
Quality Assurance
Medical Writing

Clinical Trial Management

Feasibility & Study Start Up
Project Management
Medical Affairs & Pharmacovigilance
Clinical Monitoring
Patient Recruitment
Biometrics
Training Academy

By Focus Area

Endocrinology & Metabolic

Neurology & Psychiatry

Other Focus Areas

Immunology & Vaccine

By Phase

Early Phase Studies
Phase II-III Studies
Late Phase Studies

Management

A Message from our CEO
Board of Directors
Growth Strategy

Investors Contact

Financial Information

Earnings Highlights
Financial Position
Cash Flow

IR Library

Earnings Statement
Earnings Presentation
Other Materials

Stock Information

Shareholders’ Meeting
Stock Information
Dividends

IR News
IR Calendar
Stock Quotes
FAQs
Disclaimer

LINICAL

News & Events

Corporate

All
Corporate
CRO
Event
Life at Linical
Oncology
Technology
Asia-Pacific

THE LATEST

August 1, 2024

CRO

Linical Opens a New Subsidiary in Australia

Linical expands its global coverage through establishing its first affiliate in the Southern Hemisphere Osaka, Japan (August 1, 2024) – Linical, a...

Continue Reading

SIGN UP FOR OUR NEWSLETTER

July 30, 2024

CRO

Linical Announces Clareece West as President, America and Europe

Stuart, FL (July 30, 2024) – Linical, a global Contract Research Organization (CRO) for full-service drug development, has named Clareece West as...

Continue Reading

Posts about Corporate

August 1, 2024

CRO

Linical Opens a New Subsidiary in Australia

Continue Reading

July 30, 2024

CRO

Linical Announces Clareece West as President, America and Europe

Continue Reading

July 23, 2024

CRO

Linical Named Best Global CRO by Global Health & Pharma Magazine

Continue Reading

May 13, 2024

CRO

Linical’s Website Wins Design Awards

Continue Reading

March 26, 2024

Technology

Linical Achieves ISO/IEC 27001 Information Security Certification

Continue Reading

January 24, 2024

CRO

Linical Awarded Best International CRO Honor by Industry Publication

Continue Reading

November 17, 2023

Corporate

Linical Awarded as a Top Business in Research and Development in Romania

Continue Reading

October 24, 2022

Corporate

LINICAL OPENS A NEW SUBSIDIARY IN ITALY FOR EXPANDING ITS BUSINESS IN EUROPE

Continue Reading

February 28, 2019

Corporate

The establishment of an affiliate in People’s Republic of China

Continue Reading

November 15, 2017

Corporate

Honored among the “Best Under A Billion 2017” by Forbes Asia

Continue Reading

SIGN UP FOR OUR NEWSLETTER

Services
Drug Development Strategy
Clinical Trial Management
Functional Service Provider

Therapeutic Expertise
Oncology
Neurology & Psychiatry
Immunology & Vaccine
Endocrinology & Metabolic
Other Focus Areas

About
Resource Center
Investors
Careers

Get In Touch
Contact Us
Become an Investigator
Investor Contact
Request a Proposal

© 2024 Linical. All Rights Reserved.

Privacy Policy
Terms of Use